EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Expanding Access to Noninvasive Prenatal Diagnosis for Monogenic Conditions to Consanguineous Families

Britt Hanson iD, Joe Shaw, Nikita Povarnitsyn, Benjamin Bowns, Elizabeth Young, Amy Gerrish, Stephanie Allen, Elizabeth Scotchman, Lyn S Chitty, Natalie J Chandler

Clinical Chemistry · 02.05.2024 · 70 (5) · 727-736

DOI: 10.1093/clinchem/hvae023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry, online erschienen am 09.04.2024. Verfasst von Britt Hanson und 9 weiteren Autor:innen. Beteiligte Einrichtung: North Thames Genomic Laboratory Hub, Great Ormond Street NHS Foundation Trust, London, United Kingdom. Hauptthemen laut MEDLINE: Consanguinity, Noninvasive Prenatal Testing, Haplotypes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute for Health and Care Research Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cell-free fetal DNA exists within the maternal bloodstream during pregnancy and provides a means for noninvasive prenatal diagnosis (NIPD). Our accredited clinical service offers definitive NIPD for several autosomal recessive (AR) and X-linked conditions using relative haplotype dosage analysis (RHDO). RHDO involves next-generation sequencing (NGS) of thousands of common single nucleotide polymorphism (SNPs) surrounding the gene of interest in the parents and an affected or unaffected offspring to conduct haplotype phasing of the high- and low-risk alleles. NGS is carried out in parallel on the maternal cell-free DNA, and fetal inheritance is predicted using sensitive dosage calculations performed at sites where the parental genotypes differ. RHDO is not currently offered to consanguineous couples owing to the shared haplotype between parents. Here we test the expansion of RHDO for AR monogenic conditions to include consanguineous couples.

Methods

The existing sequential probability ratio test analysis pipeline was modified to apply to SNPs where both parents are heterozygous for the same genotype. Quality control thresholds were developed using 33 nonconsanguineous cases. The performance of the adapted RHDO pipeline was tested on 8 consanguineous cases.

Results

The correct fetal genotype was predicted by our revised RHDO approach in all conclusive cases with known genotypes (n = 5). Haplotype block classification accuracies of 94.5% and 93.9% were obtained for the nonconsanguineous and consanguineous case cohorts, respectively.

Conclusions

Our modified RHDO pipeline correctly predicts the genotype in fetuses from consanguineous families, allowing the potential to expand access to NIPD services for these families.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ConsanguinityNoninvasive Prenatal TestingHaplotypesHumansFemalePregnancyPolymorphism, Single NucleotideHigh-Throughput Nucleotide SequencingCell-Free Nucleic AcidsPrenatal DiagnosisMale

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • North Thames Genomic Laboratory Hub, Great Ormond Street NHS Foundation Trust, London, United Kingdom.
  • West Midlands Regional Genetics Laboratory, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, United Kingdom.
  • Genetic and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.

ORCID-Profile: Britt Hanson

Förderung

  • National Institute for Health and Care Research Biomedical Research Centre

Zitieren

APA

Hanson, B., Shaw, J., Povarnitsyn, N., Bowns, B., Young, E., Gerrish, A., Allen, S., Scotchman, E., Chitty, L. S., & Chandler, N. J. (2024). Expanding Access to Noninvasive Prenatal Diagnosis for Monogenic Conditions to Consanguineous Families. Clinical Chemistry, 70(5), 727-736. https://doi.org/10.1093/clinchem/hvae023

Vancouver

Hanson B, Shaw J, Povarnitsyn N, Bowns B, Young E, Gerrish A, et al. Expanding Access to Noninvasive Prenatal Diagnosis for Monogenic Conditions to Consanguineous Families. Clinical Chemistry. 2024;70(5):727-736. doi:10.1093/clinchem/hvae023

BibTeX
@article{Hanson2024,
  author = {Hanson, Britt and Shaw, Joe and Povarnitsyn, Nikita and Bowns, Benjamin and Young, Elizabeth and Gerrish, Amy and Allen, Stephanie and Scotchman, Elizabeth and Chitty, Lyn S and Chandler, Natalie J},
  title = {Expanding Access to Noninvasive Prenatal Diagnosis for Monogenic Conditions to Consanguineous Families},
  journal = {Clinical Chemistry},
  year = {2024},
  volume = {70},
  number = {5},
  pages = {727--736},
  doi = {10.1093/clinchem/hvae023}
}
Kostenlos starten →